Your browser doesn't support javascript.
loading
Exploiting the CD200-CD200R immune checkpoint axis in multiple myeloma to enhance CAR T-cell therapy.
Tang, Yan; Liu, Wei; Kadu, Siddhant; Johnson, Omar; Hasanali, Zainul S; Kelly, Andre; Shestov, Alexander; Pajarillo, Raymone; Greenblatt, Eli; Holmes, Matthew; Wang, Li-Ping; Shih, Natalie; O'Connor, Roddy S; Ruella, Marco; Garfall, Alfred L; Allman, David; Vogl, Dan T; Cohen, Adam; June, Carl H; Sheppard, Neil C.
Afiliación
  • Tang Y; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA.
  • Liu W; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA.
  • Kadu S; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA.
  • Johnson O; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA.
  • Hasanali ZS; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Kelly A; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA.
  • Shestov A; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA.
  • Pajarillo R; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA.
  • Greenblatt E; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Holmes M; IsoPlexis, Bradford, CT.
  • Wang LP; IsoPlexis, Bradford, CT.
  • Shih N; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • O'Connor RS; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Ruella M; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA.
  • Garfall AL; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Allman D; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Vogl DT; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Cohen A; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA.
  • June CH; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Sheppard NC; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA.
Blood ; 143(2): 139-151, 2024 Jan 11.
Article en En | MEDLINE | ID: mdl-37616575
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunoterapia Adoptiva / Mieloma Múltiple Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Blood Año: 2024 Tipo del documento: Article País de afiliación: Panamá
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunoterapia Adoptiva / Mieloma Múltiple Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Blood Año: 2024 Tipo del documento: Article País de afiliación: Panamá